Clene Inc.

General ticker "CLNN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $39.8M (TTM average)

Clene Inc. follows the US Stock Market performance with the rate: 46.2%.

Estimated limits based on current volatility of 12.6%: low 7.43$, high 9.57$

Factors to consider:

  • Total employees count: 85 (-1.2%) as of 2023
  • Top business risk factors: Economic downturns and volatility, Product commercialization failure, Labor/talent shortage/retention, Manufacturing disruptions, Inflation impact
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.77$, 8.94$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.25$, 7.44$]

Financial Metrics affecting the CLNN estimates:

  • Positive: with PPE of -0.8 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -64.31 <= 0.33
  • Negative: negative Net income
  • Negative: Shareholder equity ratio, % of -32.40 <= 18.93
  • Negative: negative Industry operating cash flow (median)
  • Positive: Investing cash flow per share per price, % of 19.05 > -0.66

Similar symbols

Short-term CLNN quotes

Long-term CLNN plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $0.65MM $0.34MM
Operating Expenses $41.19MM $33.44MM
Operating Income $-40.54MM $-33.09MM
Non-Operating Income $-8.96MM $-6.31MM
Interest Expense $4.56MM $4.06MM
R&D Expense $26.66MM $20.06MM
Income(Loss) $-49.50MM $-39.40MM
Profit(Loss)* $-49.50MM $-39.40MM
Stockholders Equity $13.39MM $-8.86MM
Inventory $0.04MM $0.07MM
Assets $52.34MM $27.34MM
Operating Cash Flow $-30.17MM $-21.33MM
Capital expenditure $0.33MM $0.01MM
Investing Cash Flow $-1.50MM $6.32MM
Financing Cash Flow $42.16MM $-1.53MM
Earnings Per Share** $-9.43 $-5.67

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.